Scanlan Jacqueline has filed a notice to sell 4,930 shares of common stock in FMC Corp. This transaction is valued at approximately $32,291 and was reported on November 3, 2026. The sale is part of her ongoing management of equity holdings in the company.

The filing is significant as it highlights the actions of an officer within FMC Corp, a well-known entity in the chemicals and allied products sector. The company, which is incorporated in Delaware, has a long history and operates under the ticker symbol FMC on the New York Stock Exchange.

According to the filing, the shares being sold were acquired through restricted stock vesting, with 1,913 shares acquired on September 27, 2025, and 3,017 shares acquired on September 27, 2026. The nature of these transactions indicates that they were part of compensation arrangements.

The filing also notes that there have been no securities sold by Scanlan in the past three months, emphasizing that this transaction is a specific strategic move. The shares are being sold through Fidelity Brokerage Services LLC, which is based in Smithfield, Rhode Island.

As FMC Corp continues to navigate the competitive landscape of the chemicals industry, this sale by an officer may reflect broader trends in stock management and personal financial strategies among executives. The filing does not specify what actions may follow this sale.